← FDA DRUG APPROVALS

FDA NDA · NDA019228

MANGANESE SULFATE

Sponsor: ABRAXIS PHARM

APPLICATION
NDA019228
TYPE
NDA
ORIGINAL APPROVAL
1987-05-05
LATEST ACTION
1994-04-25
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MANGANESE SULFATE · ReferenceDiscontinued
MANGANESE SULFATE EQ 0.1MG MANGANESE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION

Approval history

1994-04-25Labeling · Supplement 5 · standardAP
1992-06-09Labeling · Supplement 3AP
1989-06-07Labeling · Supplement 1AP
1987-05-05Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →